altern complement pathway activ cystic fibrosi letter possibl ha rais complement play role pathogenesi cystic fibrosi cf thi impair would consist thesi altern pathway activ vivo therefor deplet purpos thi work explor function altern pathway cystic fibrosi examin data use student test analysi varianc show signific differ mean hemolyt activ sera cf patient compar control group data present support work polley bearn demonstr abnorm cf patient use convers c3 inulin assay reason thi discrep clear result preclud vivo activ altern pathway sinc compensatori increas synthesi compon could offset compon consumpt sinc net result complet normal level activ howev doe seem like signific consumpt ha occur